General Information of Drug Transporter (DT)
DT ID DTD0123 Transporter Info
Gene Name SLC18A1
Transporter Name Vesicular amine transporter 1
Gene ID
6570
UniProt ID
P54219
Post-Translational Modification of This DT
Overview of SLC18A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

58

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC18A1 Asparagine 58 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC18A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

87

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC18A1 Asparagine 87 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC18A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

104

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC18A1 Asparagine 104 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

308

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Serine 308 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC18A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

517

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Serine 517 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

322

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Threonine 322 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC18A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

499

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Threonine 499 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC18A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

504

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Threonine 504 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC18A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

508

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Threonine 508 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC18A1 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

502

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC18A1 Tyrosine 502 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: VMAT1_HUMAN)
2 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
3 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
4 Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054.
5 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.